fbpx
Πίσω
Πίσω

28-04-2021

01 Dr. Avgerinos - Dr. Tsoukalas - Welcome by moderators

01 Dr. Avgerinos - Dr. Tsoukalas - Welcome by moderators

02 Dr. Tzilves - Optimizing NET management - MDT Approach: The optimal care pathway for patients living with NET’s

02 Dr. Tzilves - Optimizing NET management - MDT Approach: T...

03 Dr.Galanopoulos - Impact of NET misdiagnosis on patients and healthcare systems - Understanding the barriers to early diagnosis

03 Dr.Galanopoulos - Impact of NET misdiagnosis on patients...

04 Dr. Dimitriadou - Results from clinical trials Clarinet & PROMID - How could physicians evaluate the key differences in the real clinical practice aligned with International Guidelines?

04 Dr. Dimitriadou - Results from clinical trials Clarinet &...

05 Dr. Dimitriadou - Results from clinical trials Clarinet & PROMID - How could physicians evaluate the key differences in the real clinical practice aligned with International Guidelines?

05 Dr. Dimitriadou - Results from clinical trials Clarinet &...

06 Dr.Tsoli -Shall we switch in GEP-NET’s as treatment strategy for these patients? - Is it important to keep patients at the center of treatment decisions? Which is the ideal profile for this action?

06 Dr.Tsoli -Shall we switch in GEP-NET’s as treatment strat...

07 Dr. Evangelou - The Greek experience: Effects on therapy during COVID-19 pandemic - Which are the key learnings?

07 Dr. Evangelou - The Greek experience: Effects on therapy...

08 Dr. Athanasakis - Greek HEOR RWD: Beyond on SSA clinical data, could physicians reinforce NET’s treatment strategy for patients based on an added pharmacoeconomical value?

08 Dr. Athanasakis - Greek HEOR RWD: Beyond on SSA clinical...

09 Closing Remarks

09 Closing Remarks

livemed white